CompanyDrug

Eli Lilly’s Kisunla Secures Market Approval in Japan for Early Symptomatic Alzheimer’s

CompanyDrug

Amgen’s Tepezza Receives Approval in Japan for Treating Thyroid Eye Disease

Company

GSK Appoints Li Weidong as Vaccine Business Head for China

CompanyDeals

Beijing Bohui Innovation Biotechnology Ends Rabies Vaccine Partnership with BOAOVAX

CompanyDeals

Nona Biosciences Partners with Alkyon Therapeutics to Develop Next-Generation Immunotherapies

CompanyDrug

Elevation Oncology’s Claudin 18.2 Targeting ADC Earns FDA Fast Track Designation for Gastric Cancer

CompanyDeals

Beijing Bohui Innovation and BOAOVAX End Collaboration on Rabies Vaccine Development

Company

InnoCare Pharma’s H1 2024 Revenue Boosted by Orelabrutinib, Anticipates Minjuvi Approval in 2025

CompanyDrug

China Medical System’s Opzelura Cream Filing for Vitiligo Accepted by NMPA

CompanyDrug

Junshi Biosciences’ Toripalimab Secures EC Nod for Two Cancer Indications

CompanyDrug

Allist Pharma’s Partner Abbisko Receives NMPA Green Light for NSCLC Drug Trial

CompanyMedical Device

Huadong Medicine’s V20 Device Receives NMPA Approval for Market Launch